DRUG
#3011
Bright Minds Biosciences Inc. - common stock
51.5 0 USD
-0.05%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-4.65%
Monatliche Änderung
-18.03%
6 month change
-40.46%
Jahresänderung
-18.25%
Vorheriger Schlusskurs
54.0 1
Open
54.2 1
Tief
50.9 9
Hoch
54.3 5
Financials
- Market Capitalization 393.24 M
- Employee 25
- Founded 2017
- CEO N/A
- Website www.brightmindsbio.com
- Headquarter British Columbia, Canada
- FIGI BBG00ZKX9FP7
- Industry Biotechnologie
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3001 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 4.06 USD | -2.87% | -5.58% | -15.42% | -55.92% | 403.76 M USD | ||
| 3007 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.99 USD | -0.80% | -1.58% | -6.03% | +55.45% | 400.22 M USD | ||
| 3021 |  EDIT Editas Medicine, Inc. - Common Stock | 2.44 USD | -11.27% | -10.62% | -9.29% | -29.07% | 374.74 M USD | ||
| 3054 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.70 USD | -4.39% | -1.60% | -6.33% | -27.88% | 373.14 M USD |